Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1599 entries
Sorted by: Best Match Show Resources per page
Effect of oral azithromycin vs placebo on COVID-19 symptoms in outpatients with SARS-CoV-2 infection: a randomized clinical trial

Latinx/Hispanic ethnicity

Oldenburg CE, Pinsky BA, Ruder K.
GSID: gkpLBSD1X4QJ
CE Oldenburg, BA Pinsky, J Brogdon, C Chen, K Ruder… - Jama, 2021 - jamanetwork.com

… Race and ethnicity were self-reported by participants based on fixed categories with the option to report an “other” race or ethnicity to comply with US Food and Drug Administration …

Cite
Oldenburg, C. E., Pinsky, B. A., Brogdon, J., Chen, C., Ruder, K., Zhong, L., ... & Doan, T. (2021). Effect of oral azithromycin vs placebo on COVID-19 symptoms in outpatients with SARS-CoV-2 infection: a randomized clinical trial. Jama, 326(6), 490-498.
Oldenburg, Catherine E., et al. "Effect of oral azithromycin vs placebo on COVID-19 symptoms in outpatients with SARS-CoV-2 infection: a randomized clinical trial." Jama 326.6 (2021): 490-498.
Copy Download .nbib Format: MLA
Estimation of population coverage for antibiotic distribution for trachoma control: a comparison of methods.

International health

Cromwell EA, Ngondi J, Gatpan G, Becknell S, Kur L, McFarland D, King JD, Emerson PM.
PMID: 24036565
Int Health. 2009 Dec;1(2):182-9. doi: 10.1016/j.inhe.2009.09.002.

Trachoma control includes mass drug administration (MDA) with antibiotics targeting coverage of at least 80%. Coverage is traditionally calculated by dividing doses distributed by population estimate, which is unreliable. We compared a verifiable coverage assessment method against self-reported participation...

Cite
Cromwell EA, Ngondi J, Gatpan G, et al. Estimation of population coverage for antibiotic distribution for trachoma control: a comparison of methods. Int Health. 2009;1(2):182-9doi: 10.1016/j.inhe.2009.09.002.
Cromwell, E. A., Ngondi, J., Gatpan, G., Becknell, S., Kur, L., McFarland, D., King, J. D., & Emerson, P. M. (2009). Estimation of population coverage for antibiotic distribution for trachoma control: a comparison of methods. International health, 1(2), 182-9. https://doi.org/10.1016/j.inhe.2009.09.002
Cromwell, Elizabeth A, et al. "Estimation of population coverage for antibiotic distribution for trachoma control: a comparison of methods." International health vol. 1,2 (2009): 182-9. doi: https://doi.org/10.1016/j.inhe.2009.09.002
Cromwell EA, Ngondi J, Gatpan G, Becknell S, Kur L, McFarland D, King JD, Emerson PM. Estimation of population coverage for antibiotic distribution for trachoma control: a comparison of methods. Int Health. 2009 Dec;1(2):182-9. doi: 10.1016/j.inhe.2009.09.002. PMID: 24036565.
Copy Download .nbib Format: NLM
[No title available]

Infection and drug resistance

Sethi S, Zaman K, Jain N.
PMID: 28979150
Infect Drug Resist. 2017 Sep 01;10:283-292. doi: 10.2147/IDR.S105469. eCollection 2017.

No abstract available.

Cite
Sethi S, Zaman K, Jain N. . Infect Drug Resist. 2017;10:283-292doi: 10.2147/IDR.S105469.
Sethi, S., Zaman, K., & Jain, N. (2017). . Infection and drug resistance, 10283-292. https://doi.org/10.2147/IDR.S105469
Sethi, Sunil, et al. "." Infection and drug resistance vol. 10 (2017): 283-292. doi: https://doi.org/10.2147/IDR.S105469
Sethi S, Zaman K, Jain N. . Infect Drug Resist. 2017 Sep 01;10:283-292. doi: 10.2147/IDR.S105469. eCollection 2017. PMID: 28979150; PMCID: PMC5589104.
Copy Download .nbib Format: NLM
Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants.

Scientific reports

Gomes C, Martínez-Puchol S, Ruiz-Roldán L, Pons MJ, Del Valle Mendoza J, Ruiz J.
PMID: 27667026
Sci Rep. 2016 Sep 26;6:33584. doi: 10.1038/srep33584.

The objective was to develop and characterise in vitro Bartonella bacilliformis antibiotic resistant mutants. Three B. bacilliformis strains were plated 35 or 40 times with azithromycin, chloramphenicol, ciprofloxacin or rifampicin discs. Resistance-stability was assessed performing 5 serial passages without...

Cite
Gomes C, Martínez-Puchol S, Ruiz-Roldán L, et al. Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants. Sci Rep. 2016;6:33584doi: 10.1038/srep33584.
Gomes, C., Martínez-Puchol, S., Ruiz-Roldán, L., Pons, M. J., Del Valle Mendoza, J., & Ruiz, J. (2016). Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants. Scientific reports, 633584. https://doi.org/10.1038/srep33584
Gomes, Cláudia, et al. "Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants." Scientific reports vol. 6 (2016): 33584. doi: https://doi.org/10.1038/srep33584
Gomes C, Martínez-Puchol S, Ruiz-Roldán L, Pons MJ, Del Valle Mendoza J, Ruiz J. Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants. Sci Rep. 2016 Sep 26;6:33584. doi: 10.1038/srep33584. PMID: 27667026; PMCID: PMC5035977.
Copy Download .nbib Format: NLM
Nitazoxanide Use as Part of an Empiric Multi-Drug Regimen in Treating Children with Suspected Helicobacter pylori Infection.

Case reports in gastroenterology

Ramos-Soriano AG, Black J.
PMID: 25759631
Case Rep Gastroenterol. 2014 Jan 27;9(1):36-42. doi: 10.1159/000375116. eCollection 2015.

Helicobacter pylori, a Gram-negative bacterium found in the human stomach, is often present in patients with chronic gastritis. Traditional treatment for H. pylori infection includes metronidazole or clarithromycin, both being associated with development of resistance. In this retrospective report,...

Cite
Ramos-Soriano AG, Black J. Nitazoxanide Use as Part of an Empiric Multi-Drug Regimen in Treating Children with Suspected Helicobacter pylori Infection. Case Rep Gastroenterol. 2014;9(1):36-42doi: 10.1159/000375116.
Ramos-Soriano, A. G., & Black, J. (2015). Nitazoxanide Use as Part of an Empiric Multi-Drug Regimen in Treating Children with Suspected Helicobacter pylori Infection. Case reports in gastroenterology, 9(1), 36-42. https://doi.org/10.1159/000375116
Ramos-Soriano, Asuncion G, and Black, Jimmy. "Nitazoxanide Use as Part of an Empiric Multi-Drug Regimen in Treating Children with Suspected Helicobacter pylori Infection." Case reports in gastroenterology vol. 9,1 (2015): 36-42. doi: https://doi.org/10.1159/000375116
Ramos-Soriano AG, Black J. Nitazoxanide Use as Part of an Empiric Multi-Drug Regimen in Treating Children with Suspected Helicobacter pylori Infection. Case Rep Gastroenterol. 2014 Jan 27;9(1):36-42. doi: 10.1159/000375116. eCollection 2015. PMID: 25759631; PMCID: PMC4327329.
Copy Download .nbib Format: NLM
ISMP Adverse Drug Reactions: Acute Disseminated Intravascular Coagulation Due to Oxaliplatin Azithromycin-Induced Stevens-Johnson Syndrome Acute Jugular Vein Thrombosis with Rituximab Hemorrhagic Bullae of the Fingers Induced by Furosemide.

Hospital pharmacy

Mancano MA.
PMID: 28179736
Hosp Pharm. 2017 Jan;52(1):13-16. doi: 10.1310/hpj5201-13.

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported...

Cite
Mancano MA. ISMP Adverse Drug Reactions: Acute Disseminated Intravascular Coagulation Due to Oxaliplatin Azithromycin-Induced Stevens-Johnson Syndrome Acute Jugular Vein Thrombosis with Rituximab Hemorrhagic Bullae of the Fingers Induced by Furosemide. Hosp Pharm. 2017;52(1):13-16doi: 10.1310/hpj5201-13.
Mancano, M. A. (2017). ISMP Adverse Drug Reactions: Acute Disseminated Intravascular Coagulation Due to Oxaliplatin Azithromycin-Induced Stevens-Johnson Syndrome Acute Jugular Vein Thrombosis with Rituximab Hemorrhagic Bullae of the Fingers Induced by Furosemide. Hospital pharmacy, 52(1), 13-16. https://doi.org/10.1310/hpj5201-13
Mancano, Michael A. "ISMP Adverse Drug Reactions: Acute Disseminated Intravascular Coagulation Due to Oxaliplatin Azithromycin-Induced Stevens-Johnson Syndrome Acute Jugular Vein Thrombosis with Rituximab Hemorrhagic Bullae of the Fingers Induced by Furosemide." Hospital pharmacy vol. 52,1 (2017): 13-16. doi: https://doi.org/10.1310/hpj5201-13
Mancano MA. ISMP Adverse Drug Reactions: Acute Disseminated Intravascular Coagulation Due to Oxaliplatin Azithromycin-Induced Stevens-Johnson Syndrome Acute Jugular Vein Thrombosis with Rituximab Hemorrhagic Bullae of the Fingers Induced by Furosemide. Hosp Pharm. 2017 Jan;52(1):13-16. doi: 10.1310/hpj5201-13. PMID: 28179736; PMCID: PMC5278909.
Copy Download .nbib Format: NLM
Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs.

Veterinary sciences

Diesel A, Moriello K.
PMID: 29061926
Vet Sci. 2015 Feb 05;2(1):13-22. doi: 10.3390/vetsci2010013.

Gingival overgrowth is an uncommon adverse effect of cyclosporine administration in veterinary species. In people, gingival overgrowth is a common complication of cyclosporine administration for immunosuppression, generally following transplant procedures. Azithromycin has been used successfully for managing gingival overgrowth...

Cite
Diesel A, Moriello K. Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs. Vet Sci. 2015;2(1):13-22doi: 10.3390/vetsci2010013.
Diesel, A., & Moriello, K. (2015). Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs. Veterinary sciences, 2(1), 13-22. https://doi.org/10.3390/vetsci2010013
Diesel, Alison, and Moriello, Karen. "Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs." Veterinary sciences vol. 2,1 (2015): 13-22. doi: https://doi.org/10.3390/vetsci2010013
Diesel A, Moriello K. Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs. Vet Sci. 2015 Feb 05;2(1):13-22. doi: 10.3390/vetsci2010013. PMID: 29061926; PMCID: PMC5644608.
Copy Download .nbib Format: NLM
Longitudinal Comparison of Antibiotic Resistance in Diarrheagenic and Non-pathogenic Escherichia coli from Young Tanzanian Children.

Frontiers in microbiology

Seidman JC, Johnson LB, Levens J, Mkocha H, Muñoz B, Silbergeld EK, West SK, Coles CL.
PMID: 27656179
Front Microbiol. 2016 Sep 07;7:1420. doi: 10.3389/fmicb.2016.01420. eCollection 2016.

Enteroaggregative, enteropathogenic, and enterotoxigenic Escherichia coli contribute significantly to the burden of diarrheal infections particularly in developing countries. Antibiotic resistance is increasingly common among bacterial pathogens including pathogenic E. coli. We assessed the relationship between pathogenic E. coli carriage...

Cite
Seidman JC, Johnson LB, Levens J, et al. Longitudinal Comparison of Antibiotic Resistance in Diarrheagenic and Non-pathogenic Escherichia coli from Young Tanzanian Children. Front Microbiol. 2016;7:1420doi: 10.3389/fmicb.2016.01420.
Seidman, J. C., Johnson, L. B., Levens, J., Mkocha, H., Muñoz, B., Silbergeld, E. K., West, S. K., & Coles, C. L. (2016). Longitudinal Comparison of Antibiotic Resistance in Diarrheagenic and Non-pathogenic Escherichia coli from Young Tanzanian Children. Frontiers in microbiology, 71420. https://doi.org/10.3389/fmicb.2016.01420
Seidman, Jessica C, et al. "Longitudinal Comparison of Antibiotic Resistance in Diarrheagenic and Non-pathogenic Escherichia coli from Young Tanzanian Children." Frontiers in microbiology vol. 7 (2016): 1420. doi: https://doi.org/10.3389/fmicb.2016.01420
Seidman JC, Johnson LB, Levens J, Mkocha H, Muñoz B, Silbergeld EK, West SK, Coles CL. Longitudinal Comparison of Antibiotic Resistance in Diarrheagenic and Non-pathogenic Escherichia coli from Young Tanzanian Children. Front Microbiol. 2016 Sep 07;7:1420. doi: 10.3389/fmicb.2016.01420. eCollection 2016. PMID: 27656179; PMCID: PMC5013055.
Copy Download .nbib Format: NLM
Azithromycin and COPD Exacerbations in the Presence or Absence of Symptoms or Active Treatment for Gastroesophageal Reflux.

Chronic obstructive pulmonary diseases (Miami, Fla.)

Ramos FL, Lindberg SM, Krahnke JS, Connett J, Albert RK, Criner GJ.
PMID: 29114567
Chronic Obstr Pulm Dis. 2014 Sep 25;1(2):221-228. doi: 10.15326/jcopdf.1.2.2014.0132.

No abstract available.

Cite
Ramos FL, Lindberg SM, Krahnke JS, et al. Azithromycin and COPD Exacerbations in the Presence or Absence of Symptoms or Active Treatment for Gastroesophageal Reflux. Chronic Obstr Pulm Dis. 2014;1(2):221-228doi: 10.15326/jcopdf.1.2.2014.0132.
Ramos, F. L., Lindberg, S. M., Krahnke, J. S., Connett, J., Albert, R. K., Criner, G. J. (2014). Azithromycin and COPD Exacerbations in the Presence or Absence of Symptoms or Active Treatment for Gastroesophageal Reflux. Chronic obstructive pulmonary diseases (Miami, Fla.), 1(2), 221-228. https://doi.org/10.15326/jcopdf.1.2.2014.0132
Ramos, Frederick L, et al. "Azithromycin and COPD Exacerbations in the Presence or Absence of Symptoms or Active Treatment for Gastroesophageal Reflux." Chronic obstructive pulmonary diseases (Miami, Fla.) vol. 1,2 (2014): 221-228. doi: https://doi.org/10.15326/jcopdf.1.2.2014.0132
Ramos FL, Lindberg SM, Krahnke JS, Connett J, Albert RK, Criner GJ. Azithromycin and COPD Exacerbations in the Presence or Absence of Symptoms or Active Treatment for Gastroesophageal Reflux. Chronic Obstr Pulm Dis. 2014 Sep 25;1(2):221-228. doi: 10.15326/jcopdf.1.2.2014.0132. PMID: 29114567; PMCID: PMC5593427.
Copy Download .nbib Format: NLM
Distribution of Genes Encoding Resistance to Macrolides Among Staphylococci Isolated From the Nasal Cavity of Hospital Employees in Khorramabad, Iran.

Iranian Red Crescent medical journal

Goudarzi G, Tahmasbi F, Anbari K, Ghafarzadeh M.
PMID: 27195143
Iran Red Crescent Med J. 2016 Feb 27;18(2):e25701. doi: 10.5812/ircmj.25701. eCollection 2016 Feb.

BACKGROUND: Epidemiological data on antibiotic susceptibility of Staphylococcus strains isolated from nasal carriers in each region can be helpful to select appropriate drugs to eradicate carriage states, control nosocomial infections and also treat patients.OBJECTIVES: The current study aimed to...

Cite
Goudarzi G, Tahmasbi F, Anbari K, et al. Distribution of Genes Encoding Resistance to Macrolides Among Staphylococci Isolated From the Nasal Cavity of Hospital Employees in Khorramabad, Iran. Iran Red Crescent Med J. 2016;18(2):e25701doi: 10.5812/ircmj.25701.
Goudarzi, G., Tahmasbi, F., Anbari, K., & Ghafarzadeh, M. (2016). Distribution of Genes Encoding Resistance to Macrolides Among Staphylococci Isolated From the Nasal Cavity of Hospital Employees in Khorramabad, Iran. Iranian Red Crescent medical journal, 18(2), e25701. https://doi.org/10.5812/ircmj.25701
Goudarzi, Gholamreza, et al. "Distribution of Genes Encoding Resistance to Macrolides Among Staphylococci Isolated From the Nasal Cavity of Hospital Employees in Khorramabad, Iran." Iranian Red Crescent medical journal vol. 18,2 (2016): e25701. doi: https://doi.org/10.5812/ircmj.25701
Goudarzi G, Tahmasbi F, Anbari K, Ghafarzadeh M. Distribution of Genes Encoding Resistance to Macrolides Among Staphylococci Isolated From the Nasal Cavity of Hospital Employees in Khorramabad, Iran. Iran Red Crescent Med J. 2016 Feb 27;18(2):e25701. doi: 10.5812/ircmj.25701. eCollection 2016 Feb. PMID: 27195143; PMCID: PMC4867334.
Copy Download .nbib Format: NLM
Azithromycin inhibits nuclear factor-κB activation during lung inflammation: an in vivo imaging study.

Pharmacology research & perspectives

Stellari FF, Sala A, Donofrio G, Ruscitti F, Caruso P, Topini TM, Francis KP, Li X, Carnini C, Civelli M, Villetti G.
PMID: 25505605
Pharmacol Res Perspect. 2014 Oct;2(5):e00058. doi: 10.1002/prp2.58. Epub 2014 Jul 02.

We studied in vivo the potential involvement of nuclear factor-κB (NF-κB) pathway in the molecular mechanism of the anti-inflammatory and immunomodulatory activity of azithromycin in the lung. Mice transiently transfected with the luciferase gene under the control of a...

Cite
Stellari FF, Sala A, Donofrio G, et al. Azithromycin inhibits nuclear factor-κB activation during lung inflammation: an in vivo imaging study. Pharmacol Res Perspect. 2014;2(5):e00058doi: 10.1002/prp2.58.
Stellari, F. F., Sala, A., Donofrio, G., Ruscitti, F., Caruso, P., Topini, T. M., Francis, K. P., Li, X., Carnini, C., Civelli, M., & Villetti, G. (2014). Azithromycin inhibits nuclear factor-κB activation during lung inflammation: an in vivo imaging study. Pharmacology research & perspectives, 2(5), e00058. https://doi.org/10.1002/prp2.58
Stellari, Fabio F, et al. "Azithromycin inhibits nuclear factor-κB activation during lung inflammation: an in vivo imaging study." Pharmacology research & perspectives vol. 2,5 (2014): e00058. doi: https://doi.org/10.1002/prp2.58
Stellari FF, Sala A, Donofrio G, Ruscitti F, Caruso P, Topini TM, Francis KP, Li X, Carnini C, Civelli M, Villetti G. Azithromycin inhibits nuclear factor-κB activation during lung inflammation: an in vivo imaging study. Pharmacol Res Perspect. 2014 Oct;2(5):e00058. doi: 10.1002/prp2.58. Epub 2014 Jul 02. PMID: 25505605; PMCID: PMC4186419.
Copy Download .nbib Format: NLM
Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma.

Journal of tropical medicine

Ho DK, Sawicki C, Grassly N.
PMID: 26557143
J Trop Med. 2015;2015:917370. doi: 10.1155/2015/917370. Epub 2015 Oct 18.

Trachoma is caused by Chlamydia trachomatis and is a leading cause of blindness worldwide. Mass distribution of azithromycin (AZM) is part of the strategy for the global elimination of blinding trachoma by 2020. Although resistance to AZM in C....

Cite
Ho DK, Sawicki C, Grassly N. Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma. J Trop Med. 2015;2015:917370doi: 10.1155/2015/917370.
Ho, D. K., Sawicki, C., & Grassly, N. (2015). Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma. Journal of tropical medicine, 2015917370. https://doi.org/10.1155/2015/917370
Ho, Derek K-H, et al. "Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma." Journal of tropical medicine vol. 2015 (2015): 917370. doi: https://doi.org/10.1155/2015/917370
Ho DK, Sawicki C, Grassly N. Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma. J Trop Med. 2015;2015:917370. doi: 10.1155/2015/917370. Epub 2015 Oct 18. PMID: 26557143; PMCID: PMC4628654.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1599 entries